This website is intended to equip government officials, sheriffs, attorneys, judges and medical doctors with adequate supporting evidence to justify mandating emergency double-blind, placebo-controlled, peer-reviewed clinical trials on oral chlorine dioxide as treatment for COVID-19 and/or its variants. Clinical trial reference number NCT0434374 outlines and explains the protocol.
Regarding healthcare professionals treating patients using unproven interventions in clinical practice, the World Medical Association (WMA) International Code of Medical Ethics states that “In the treatment of an individual patient, where proven interventions do not exist or other known interventions have been ineffective, the physician, after seeking expert advice, with informed consent from the patient or a legally authorized representative, may use an unproven intervention if in the physician’s judgement it offers hope of saving life, re-establishing health or alleviating suffering. This intervention should subsequently be made the object of research, designed to evaluate its safety and efficacy. In all cases, new information must be recorded and, where appropriate, made publicly available. A physician shall act in the patient’s best interest when providing medical care.”